| Arthritis Ease Study (NCT05721352) | Arizona State University | 2022-09-15 |
| Safety and Efficacy of RX-af01 Combined With PD-1 Antibody (NCT05576961) | Sun Yat-sen University | 2022-09-15 |
| Exploratory Trial to Evaluate the Pharmacokinetic Properties and Safety of CKD-828 in Healthy Subjects (NCT05540912) | Chong Kun Dang Pharmaceutical | 2022-09-15 |
| Dose Dense Re-challenge of High Dose Methotrexate With Glucarpidase for Relapsed Primary Central Nervous System Lymphoma (NCT05135858) | Assistance Publique - Hôpitaux de Paris | 2022-09-15 |
| A Single Ascending Dose Study of JNJ-88260237 in Healthy Participants (NCT05541315) | Janssen Research & Development, LLC | 2022-09-14 |
| Study of the Breast Milk Pharmacokinetics of Olanzapine and Samidorphan (NCT05547100) | Alkermes, Inc. | 2022-09-14 |
| A Study of [14C]GB491 in Male Healthy Subjects (NCT05860582) | Genor Biopharma Co., Ltd. | 2022-09-14 |
| A Study to Evaluate the Safety and Tolerability of BMS-986403 in Participants With Relapsed and/or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (NCT05244070) | Bristol-Myers Squibb | 2022-09-14 |
| DPCP to Treat Cutaneous Neurofibromas Associated With NF1 (NCT05438290) | Nicholas Gulati | 2022-09-14 |
| Metronomic Chemotherapy in Wilms Tumor (MetroWilms-1906) (NCT05384821) | Centre Oscar Lambret | 2022-09-14 |
| Fed-Fast Crossover Study to Assess the Effect of Food With CTx-1301 in Healthy Subjects (NCT04449250) | Cingulate Therapeutics | 2022-09-14 |
| Clinical Study of Autologous Tumor-infiltrating Lymphocyte Injection (GT201) for Advanced Solid Tumors (NCT05729399) | Grit Biotechnology | 2022-09-14 |
| Safety and Immunogenicity of AdCLD-CoV19-1 OMI as a Booster: A SARS-CoV-2 (COVID-19) Preventive Vaccine (NCT05576623) | Cellid Co., Ltd. | 2022-09-14 |
| Phase 1 Study of LQT-1213 in Healthy Adults (NCT05759962) | Thryv Therapeutics, Inc. | 2022-09-14 |
| Efficacy and Safety of Acetaminophen in Postoperative Pain Management of Infants (NCT05564819) | Nanjing Children's Hospital | 2022-09-14 |
| A Clinical Study to Evaluate B4T2-001 CAR T Cells in the Treatment of Advanced Solid Tumors (NCT05621486) | Shanghai East Hospital | 2022-09-14 |
| To Evaluate the Efficacy and Safety of TQC3564 Tablets in the Treatment of Persistent Allergic Rhinitis (NCT05607446) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2022-09-14 |
| A Study of Donanemab (LY3002813) in Healthy Chinese Participants (NCT05533411) | Eli Lilly and Company | 2022-09-14 |
| The Absorption, Metabolism and Excretion of [14C]APG-2575 in Healthy Subjects (NCT05517616) | Ascentage Pharma Group Inc. | 2022-09-14 |
| Pharmacokinetics of Irbesartan/Amlodipine FDC and Co-administration of Irbesartan and Amlodipine in Healthy Volunteers (NCT05663073) | Handok Inc. | 2022-09-13 |
| Food Effect on Ceftibuten/VNRX-7145 in Healthy Participants (NCT05527834) | Basilea Pharmaceutica | 2022-09-13 |
| Study of Sotorasib Combined With Chemotherapy for Second Line Treatment of Pancreas Cancer (NCT05251038) | Devalingam Mahalingam | 2022-09-13 |
| Safety and Immunogenicity of CJCV2 With and Without ALFQ (NCT05500417) | National Institute of Allergy and Infectious Diseases (NIAID) | 2022-09-13 |
| A Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of Olpasiran in Participants With Various Degrees of Hepatic Impairment (NCT05481411) | Amgen | 2022-09-13 |
| T-ACE Oil by TAE/TACE in Patients With Hepatocellular Carcinoma (NCT05435014) | T-ACE Medical Co., Ltd | 2022-09-13 |
| A Study to Evaluate D-1553 in Combination Therapy in Non-Small Cell Lung Cancer (NCT05492045) | InventisBio Co., Ltd | 2022-09-13 |
| Comparative Bioavailability of Betamethasone Oral Solution Metered Spray (GTX-102) in Healthy Subjects (NCT05531890) | Grace Therapeutics Inc. | 2022-09-13 |
| Combination of Radium-223 and Lutetium-177 PSMA-I&T in Men with Metastatic Castration-Resistant Prostate Cancer (NCT05383079) | Peter MacCallum Cancer Centre, Australia | 2022-09-13 |
| Non-randomized, Open-label Study of Intralesional Nivolumab for High Risk Oral Premalignant Lesions (NCT05327270) | M.D. Anderson Cancer Center | 2022-09-13 |
| Evaluation of Corfluvec Vaccine for the Prevention of COVID-19 in Healthy Volunteers (NCT05696067) | Tatyana Zubkova | 2022-09-13 |
| A Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of Olpasiran in Participants With Normal Renal Function and Participants With Various Degrees of Renal Impairment (NCT05489614) | Amgen | 2022-09-13 |
| Safety and Tolerability of IMM01-STEM in Patients With Muscle Atrophy Related to Knee Osteoarthritis. (NCT05211986) | Immunis, Inc. | 2022-09-13 |
| A Study to Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nontyphoidal Salmonella and Typhoid Fever (NCT05480800) | GlaxoSmithKline | 2022-09-13 |
| An Open Label, Balanced, Randomized, 3×3 Latin Square Design Comparing of Brivaracetam Sustained-release Tablets and Brivaracetam Tablets in the Oral Comparative Pharmacokinetic(PK) Study in Chinese Healthy Adult Subjects Under Fasting Conditions. (NCT05622370) | Overseas Pharmaceuticals, Ltd. | 2022-09-13 |
| Study of Harmine in Healthy Subjects (NCT05526430) | James Murrough | 2022-09-13 |
| Fluorine-18-AlphaVBeta6-Binding Peptide Positron Emission Tomography in Metastatic Non-Small Cell Lung Cancer (NCT05452005) | University of California, Davis | 2022-09-13 |
| A Study to Assess S-217622 in Participants With Mild and Moderate Hepatic Impairment and Healthy Control Participants (NCT05409911) | Shionogi | 2022-09-13 |
| A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adults With Hodgkin and Non-Hodgkin Lymphoma (NCT05255601) | Bristol-Myers Squibb | 2022-09-13 |
| Safety and Tolerability, PK, and PD Study of Single and Multiple ALXN2080 Doses in Healthy Participants (NCT05428696) | Alexion Pharmaceuticals, Inc. | 2022-09-12 |
| Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS) (NCT05308264) | Rigel Pharmaceuticals | 2022-09-12 |
| A Study to Evaluate the Drug Exposure of Single Ascending Doses of BMS-986369 and the Effect of Food on the BMS-986369 in Healthy Participants (NCT05350800) | Bristol-Myers Squibb | 2022-09-12 |
| Safety, Tolerability, PK/PD & Preliminary Efficacy of SKL27969 in Advanced Solid Tumors Patients (NCT05388435) | SK Life Science, Inc. | 2022-09-12 |
| Safety and Immunogenicity of RVM-V001 in Healthy Individuals Previously Vaccinated With BNT162b2 and mRNA-1273 (NCT05420077) | RVAC Medicines (US), Inc. | 2022-09-12 |
| Pharmacokinetics and Safety of DolutegravIr in Neonate (NCT05590325) | Desmond Tutu TB Centre | 2022-09-12 |
| A Drug-Drug Interaction Study to Assess the CYP1A2 and CYP3A4 Interaction Potential of TEV-56286 (anle138b) (NCT05532358) | MODAG GmbH | 2022-09-12 |
| A Study of Imlunestrant (LY3484356) in Healthy Women (NCT05509816) | Eli Lilly and Company | 2022-09-12 |
| IVIG vs SCIG in CIDP (NCT05584631) | Rutgers, The State University of New Jersey | 2022-09-11 |
| Phase I/IIa Study of BR790 in Combination With Tislelizumab in Adult Subjects With Advanced Solid Tumors (NCT05505877) | Shanghai Gopherwood Biotech Co., Ltd. | 2022-09-10 |
| A Study of ABI-2280 Vaginal Insert (Previously Referred to as ABI-2280 Vaginal Tablet) in Participants With Cervical Intraepithelial Neoplasia (NCT05502367) | Antiva Biosciences | 2022-09-10 |
| A Study of Melphalan in People With Lymphoma Getting an Autologous Hematopoietic Cell Transplant (NCT05540340) | Memorial Sloan Kettering Cancer Center | 2022-09-09 |
| Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer (NCT05400122) | David Wald | 2022-09-09 |
| A Study to Evaluate Single and Multiple Doses of TLC-2716 in Healthy Participants (NCT05483998) | OrsoBio, Inc | 2022-09-09 |
| Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells Exosomes for Trigeminal Neuralgia (NCT05152368) | The Foundation for Orthopaedics and Regenerative Medicine | 2022-09-09 |
| Stem Cell Treatment of Peyronie´s Disease. (NCT04771442) | Esbjerg Hospital - University Hospital of Southern Denmark | 2022-09-09 |
| Comparing Supplemental Topical Agents for the Treatment of Acute Radiation Dermatitis in Patients With Breast Cancer (NCT05340673) | City of Hope Medical Center | 2022-09-09 |
| Intratumoral CAN1012(selective TLR7 Agonist) in Subjects with Solid Tumors (NCT05580991) | Canwell Biotech Limited | 2022-09-09 |
| Ph I Study in Adult Patients With Relapsed or Refractory Multiple Myeloma (NCT05027594) | Nerviano Medical Sciences | 2022-09-09 |
| Evaluation of PET 18F-Fludarabine for the Initial Assessment and End-treatment of Symptomatic Multiple Myeloma Patients (NCT03832127) | Nantes University Hospital | 2022-09-09 |
| Dose Confirmation and Dose Expansion Phase 1 Study of IO-108 and IO-108 + Anti-PD-1 in Solid Tumors (NCT05508100) | Immune-Onc Therapeutics | 2022-09-09 |
| An Acupuncture Study for Prostate Cancer Survivors With Urinary Issues (NCT05540392) | Memorial Sloan Kettering Cancer Center | 2022-09-09 |
| A Study Evaluating the Safety and Efficacy of HB0028 in Subjects With Advanced Solid Tumors (NCT06223308) | Shanghai Huaota Biopharmaceutical Co., Ltd. | 2022-09-09 |
| A Study of PBI-200 With Ritonavir or Cobicistat in Healthy Volunteers (NCT05692570) | Pyramid Biosciences | 2022-09-09 |
| Safety and Efficacy of HMI-203 in ERT-Treated Adults With MPS II (NCT05238324) | Homology Medicines, Inc | 2022-09-08 |
| A Study in Healthy Men to Test How BI 685509 is Processed in the Body (NCT05515328) | Boehringer Ingelheim | 2022-09-08 |
| Ivosidenib + mFOLFIRINOX in Patients With Resectable Pancreatic Adenocarcinoma (NCT05209074) | Case Comprehensive Cancer Center | 2022-09-08 |
| ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer (NCT05501769) | Arvinas Estrogen Receptor, Inc. | 2022-09-08 |
| Testing the Addition of Ipatasertib to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) for Stage III or IV Epithelial Ovarian Cancer (NCT05276973) | National Cancer Institute (NCI) | 2022-09-08 |
| A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses (NCT05491642) | Bayer | 2022-09-08 |
| Safety, Tolerability, and Immunogenicity of ALFQ in a HIV Vaccine Containing A244 and B.65321 in Healthy Adults (NCT05423418) | U.S. Army Medical Research and Development Command | 2022-09-08 |
| Peanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut Allergy (NCT05440643) | ALK-Abelló A/S | 2022-09-07 |
| Phase I, Open-Label, Study of Tumor Infiltrating Lymphocytes Engineered With Membrane Bound IL15 Plus Acetazolamide in Adult Patients With Metastatic Melanoma (NCT05470283) | M.D. Anderson Cancer Center | 2022-09-07 |
| A Trial to Assess the Effects of Prazosin or Propranolol on Blood Pressure in the Presence of Brexpiprazole/Sertraline (NCT05189977) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2022-09-07 |
| A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease (NCT05487040) | Pfizer | 2022-09-07 |
| A Mass Balance Study of [14C] TAS-303 in Healthy Adult Male Subjects (NCT05621447) | Taiho Pharmaceutical Co., Ltd. | 2022-09-07 |
| AME Study of [14C]-PC14586 in Healthy Male Participants (NCT05523687) | PMV Pharmaceuticals, Inc | 2022-09-06 |
| A Study of Dapansutrile Plus Pembrolizumab in Patients With PD-1 Refractory Advanced Melanoma (NCT04971499) | April Salama, M.D. | 2022-09-06 |
| A Study to Evaluate THB001 in Adult Patients With Chronic Cold Urticaria (NCT05510843) | Third Harmonic Bio, Inc. | 2022-09-06 |
| A Safety, Pharmacokinetics and Pharmacodynamics Study of GNR-086 and Ilaris® in Healthy Volunteers (NCT06481189) | AO GENERIUM | 2022-09-06 |
| Pharmacokinetics of Cotadutide in Participants With Hepatic Impairment (NCT05517226) | AstraZeneca | 2022-09-06 |
| A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants (NCT05533801) | Eisai Inc. | 2022-09-06 |
| A Multiple Dose Study of the Safety and Pharmacokinetics of NTRX-07 (NCT06194552) | NeuroTherapia, Inc. | 2022-09-06 |
| Pharmacokinetics of Delgocitinib 20 mg/g Cream in Subjects With Chronic Hand Eczema (NCT05486117) | LEO Pharma | 2022-09-06 |
| A Study to Assess the Effects of BMS-986371 on the Drug Levels of Methotrexate in the Presence and Absence of Sulfasalazine (NCT05445440) | Bristol-Myers Squibb | 2022-09-06 |
| A Study of TmPSMA-02 Chimeric Antigen Receptor (CAR) T-cells in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC) (NCT05489991) | Tceleron Therapeutics, Inc. | 2022-09-06 |
| Leg Heat Therapy in Elderly Individuals (NCT05543980) | Purdue University | 2022-09-05 |
| A Clinical Study of Efinopegdutide (MK-6024) in Healthy Chinese Volunteers (MK-6024-011) (NCT06836037) | Merck Sharp & Dohme LLC | 2022-09-05 |
| Study of BGB-11417 Monotherapy in Participants With Relapsed or Refractory Mantle Cell Lymphoma (NCT05471843) | BeiGene | 2022-09-05 |
| Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-101 in Participants With Myotonic Dystrophy Type 1 (NCT05481879) | Dyne Therapeutics | 2022-09-05 |
| Tamoxifen and SUBA-Itraconzole Combination Testing in Ovarian Cancer (NCT05156892) | Anthony Joshua, FRACP | 2022-09-04 |
| Pharmacokinetic Characteristics and Safety After Administration of NVP-2002 (NCT04961905) | NVP Healthcare | 2022-09-03 |
| A Study to Examine the Effect of Daridorexant on the Way the Body Absorbs, Distributes, and Gets Rid of Dabigatran and Rosuvastatin in Healthy Male Subjects (NCT05480475) | Idorsia Pharmaceuticals Ltd. | 2022-09-03 |
| AI-09 In Subjects With Glabellar Lines, GL-101 (NCT05565950) | Eirion Therapeutics Inc. | 2022-09-03 |
| A Study of Single and Multiple Dose Administration of LP-001 in Healthy Subjects (NCT06294275) | Longbio Pharma | 2022-09-03 |
| Venetoclax, Dasatinib, Prednisone, Rituximab and Blinatumomab for the Treatment of Newly Diagnosed or Relapsed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia or Mixed Phenotype Acute Leukemia (NCT04872790) | OHSU Knight Cancer Institute | 2022-09-02 |
| A Study of ZT002 in Healthy Participants (NCT05491421) | QL Biopharmaceutical Australia Pty Ltd | 2022-09-02 |
| Safety, Efficacy and Pharmacokinetics of ThisCART19A in Patients With Refractory or Relapsed B Cell Lymphoma (NCT05535673) | Zhengzhou University | 2022-09-02 |
| First-In-Human Study in Subjects With Advanced or Metastatic Solid Malignant Tumors (NCT05494918) | Alphamab (Australia) Co Pty Ltd. | 2022-09-02 |
| A Study to Evaluate the Pharmacokinetics and Safety Between HCP2202 and Co-administration of Each Component in Healthy Volunteers (NCT05548387) | Hanmi Pharmaceutical Company Limited | 2022-09-02 |
| A Clinical Trial of TQB2450 Injection Combined With AL2846 Capsules in Patients With Advanced Solid Tumors (NCT06116240) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2022-09-02 |
| Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc (NCT05366179) | UNC Lineberger Comprehensive Cancer Center | 2022-09-02 |